Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study.

Paul LesnyMark AndersonGavin ClohertyMichael StecAnja Haase-Fielitz Mathias HaarhausCarla SantosCarlos LucasFernando MacarioMichael Haase

Published in: Journal of nephrology (2021)

Two weeks after their first mRNA- or vector-based SARS-CoV-2 vaccination, hemodialysis patients demonstrated lower antibody-related response than peritoneal dialysis patients and healthy staff or unvaccinated hemodialysis patients following prior COVID-19 infection.

Keyphrases

end stage renal disease
peritoneal dialysis
chronic kidney disease
sars cov
ejection fraction
newly diagnosed
prognostic factors
coronavirus disease
patient reported